Senl_B19 autologous CAR-T (S1904) treatment Clinical Trials

1 actively recruiting trial

Top Sponsors

Peking University People's Hospital1

Indications

Relapsed Pediatric ALL1
Relapsed Adult ALL1
Refractory Acute Lymphoblastic Leukemia1
B-cell Acute Lymphoblastic Leukemia1
Cancer1

Other1 trial

Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.